Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Reversible protein inactivation by optogenetic trapping in cells

Abstract

We present a versatile platform to inactivate proteins in living cells using light, light-activated reversible inhibition by assembled trap (LARIAT), which sequesters target proteins into complexes formed by multimeric proteins and a blue light–mediated heterodimerization module. Using LARIAT, we inhibited diverse proteins that modulate cytoskeleton, lipid signaling and cell cycle with high spatiotemporal resolution. Use of single-domain antibodies extends the method to target proteins containing specific epitopes, including GFP.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Blue light–induced cluster formation.
Figure 2: Inhibition of CRY2-conjugated proteins by light-inducible trapping in clusters.
Figure 3: Inhibition of target proteins by trapping via CRY2-conjugated single-domain antibodies.

Similar content being viewed by others

References

  1. Doupé, D.P. & Perrimon, N. Sci. Signal. 7, re1 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Turgeon, B. & Meloche, S. Physiol. Rev. 89, 1–26 (2009).

    Article  CAS  PubMed  Google Scholar 

  3. Stockwell, B.R. Nature 432, 846–854 (2004).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Zhou, P. Curr. Opin. Chem. Biol. 9, 51–55 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Banaszynski, L.A., Maynard-Smith, L., Chen, L.C. & Wandless, T.J. Chem. Biol. 13, 11–21 (2006).

    Article  CAS  PubMed  Google Scholar 

  6. Wu, Y.I. et al. Nature 461, 104–108 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Levskaya, A., Weiner, O.D., Lim, W.A. & Voigt, C.A. Nature 461, 997–1001 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kennedy, M.J. et al. Nat. Methods 7, 973–975 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bugaj, L.J., Choksi, A.T., Mesuda, C.K., Kane, R.S. & Schaffer, D.V. Nat. Methods 10, 249–252 (2013).

    Article  CAS  PubMed  Google Scholar 

  10. Lee, S., Lee, K.H., Ha, J.S., Lee, S.G. & Kim, T.K. Angew. Chem. Int. Edn. 50, 8709–8713 (2011).

    Article  CAS  Google Scholar 

  11. Rosenberg, O.S., Deindl, S., Sung, R.J., Nairn, A.C. & Kuriyan, J. Cell 123, 849–860 (2005).

    Article  CAS  PubMed  Google Scholar 

  12. Liu, H.T. et al. Science 322, 1535–1539 (2008).

    Article  CAS  PubMed  Google Scholar 

  13. Lee, K.H., Lee, S., Lee, W.Y., Yang, H.W. & Heo, W.D. Proc. Natl. Acad. Sci. USA 107, 3412–3417 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Aoki, K., Nakamura, T., Fujikawa, K. & Matsuda, M. Mol. Biol. Cell 16, 2207–2217 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Riedl, J. et al. Nat. Methods 5, 605–607 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Misawa, K. et al. Proc. Natl. Acad. Sci. USA 97, 3062–3066 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Matsuyama, A. et al. Nat. Biotechnol. 24, 841–847 (2006).

    Article  CAS  PubMed  Google Scholar 

  18. Huh, W.K. et al. Nature 425, 686–691 (2003).

    Article  CAS  PubMed  Google Scholar 

  19. Rothbauer, U. et al. Nat. Methods 3, 887–889 (2006).

    Article  CAS  PubMed  Google Scholar 

  20. Jordan, M.A. & Wilson, L. Nat. Rev. Cancer 4, 253–265 (2004).

    Article  CAS  PubMed  Google Scholar 

  21. Held, M. et al. Nat. Methods 7, 747–754 (2010).

    Article  CAS  PubMed  Google Scholar 

  22. Yang, X., Jost, A.P.-T., Weiner, O.D. & Tang, C. Mol. Biol. Cell 24, 2419–2430 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Shen, K. & Meyer, T. J. Neurochem. 70, 96–104 (1998).

    Article  CAS  PubMed  Google Scholar 

  24. Campbell, R.E. et al. Proc. Natl. Acad. Sci. USA 99, 7877–7882 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Heo, W.D. & Meyer, T. Cell 113, 315–328 (2003).

    Article  CAS  PubMed  Google Scholar 

  26. Livet, J. et al. Nature 450, 56–62 (2007).

    Article  CAS  PubMed  Google Scholar 

  27. Yang, H.W. et al. Mol. Cell 47, 281–290 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kaech, S. & Banker, G. Nat. Protoc. 1, 2406–2415 (2006).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank C.L. Tucker (University of Colorado) for cDNAs encoding CRY2PHR-mCherry and CIBN-pmEGFP, T. Inoue (Johns Hopkins University) for cDNA encoding YFP-PHBtk and M. Matsuda (Kyoto University) for cDNA encoding Raichu-Rac1. This work was supported by the National Research Foundation of Korea Stem Cell Program (no. 2011-0019509), the Intelligent Synthetic Biology Center of Global Frontier Project (no. 2011-0031955) and the Korea Advanced Institute of Science and Technology Future Systems Healthcare Project funded by the Ministry of Science, Information and Communication Technology & Future Planning in Korea.

Author information

Authors and Affiliations

Authors

Contributions

W.D.H. and S.L. conceived the idea and directed the work. S.L., H.P., T.K., N.Y.K., S.K. and J.K. performed experiments. W.D.H., S.L., H.P. and T.K. wrote the manuscript.

Corresponding author

Correspondence to Won Do Heo.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–22, Supplementary Table 1 and Supplementary Note (PDF 9325 kb)

Rapid and reversible cluster formation upon blue-light illumination.

A HeLa cell co-expressing CRY2-mCherry and CIB1-mCerulean-MP was briefly stimulated by blue light (488 nm, 6.5 μW). Fluorescent images of CRY2-mCherry were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 2742 kb)

Spatiotemporal control of cluster formation in multiple cells upon blue-light illumination.

Three HeLa cells co-expressing CRY2-mCherry and CIB1-mCerulean-MP were sequentially stimulated by blue light (488 nm, 6.5 μW for each cell) at different time points indicated by arrows. Fluorescent images of CRY2-mCherry were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 3993 kb)

Spatiotemporal control of cluster formation at the subcellular level upon blue-light illumination.

Three different regions (12 μm in diameter) of a HeLa cell were sequentially stimulated by blue light (488 nm, 6.5 μW for each region) indicated by white-lined circles. Fluorescent images of CRY2-mCherry were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 2960 kb)

Reversible inactivation of Vav2 visualized by cell morphological changes.

A NIH3T3 cell co-expressing mCherry-Lifeact, mCitrine-CRY2-Vav2, and CIB1-mCerulean-MP was stimulated twice by blue light (488 nm) at a 20-minute interval. Fluorescent images of mCherry-Lifeact were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 5386 kb)

Inactivation of Vav2 in numerous cells in a wide field of view.

NIH3T3 cells co-expressing mCherry-Lifeact, mCitrine-CRY2-Vav2, and CIB1-mCerulean-MP were stimulated by blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 4714 kb)

Spatiotemporal inactivation of Vav2 at the subcellular level.

A NIH3T3 cell co-expressing mCherry-Lifeact, mCitrine-CRY2-Vav2, and CIB1-mCerulean-MP was stimulated by blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 2934 kb)

Changing cell polarity through local and sustained inactivation of Vav2.

A small region (indicated by yellow circles) of a NIH3T3 cell co-expressing mCherry-Lifeact, mCitrine-CRY2-Vav2, and CIB1-mCerulean-MP was repeatedly illuminated by blue light (488 nm) at 2-minute intervals for 46 minutes. Fluorescent images of mCherry-Lifeact were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 8119 kb)

Inactivation of GFP-Vav2 by cluster-trapping with a CRY2-conjugated anti-GFP nanobody.

NIH3T3 cells co-expressing mCherry-Lifeact, CLIP-CRY2-VHH(GFP), CIB1-SNAP-MP, and EGFP-Vav2 were exposed to blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 20 seconds. Numbers indicate minutes:seconds. (AVI 2968 kb)

Inactivation of GFP-Tiam1 by cluster-trapping with a CRY2-conjugated anti-GFP nanobody.

NIH3T3 cells co-expressing mCherry-Lifeact, CLIP-CRY2-VHH(GFP), CIB1-SNAP-MP, and EGFP-Tiam1 were exposed to blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 10 seconds. Numbers indicate minutes:seconds. (AVI 3713 kb)

Inactivation of GFP-Rac1 by cluster-trapping with a CRY2-conjugated anti-GFP nanobody.

NIH3T3 cells co-expressing mCherry-Lifeact, CLIP-CRY2-VHH(GFP), CIB1-SNAP-MP, and EGFP-Rac1 were exposed to blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 10 seconds. Numbers indicate minutes:seconds. (AVI 3371 kb)

Inactivation of GFP-RhoG by cluster-trapping with a CRY2-conjugated anti-GFP nanobody.

NIH3T3 cells co-expressing mCherry-Lifeact, CLIP-CRY2-VHH(GFP), CIB1-SNAP-MP, and EGFP-RhoG were exposed to blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 10 seconds. Numbers indicate minutes:seconds. (AVI 2376 kb)

Inactivation of GFP-Cdc42 by cluster-trapping with a CRY2-conjugated anti-GFP nanobody.

NIH3T3 cells co-expressing mCherry-Lifeact, CLIP-CRY2-VHH(GFP), CIB1-SNAP-MP, and EGFP-Cdc42 were exposed to blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 10 seconds. Numbers indicate minutes:seconds. (AVI 4269 kb)

Inactivation of CFP-PI3KCAAX visualized by dissociation of PIP3 biosensor from the plasma membrane.

NIH3T3 cells co-expressing mCherry-PHBtk, CLIP-CRY2-VHH(GFP), CIB1-SNAP-MP, and ECFP-p110CAAX were exposed to blue light (488 nm). Fluorescent images of mCherry-PHBtk were captured in every 10 seconds. Numbers indicate minutes:seconds. (AVI 1210 kb)

Inactivation of CFP-PI3KCAAX visualized by cell morphological changes upon cluster-trapping with a CRY2-conjugated anti-GFP nanobody.

NIH3T3 cells co-expressing mCherry-Lifeact, CLIP-CRY2-VHH(GFP), CIB1-SNAP-MP, and ECFP-p110CAAX were exposed to blue light (488 nm). Fluorescent images of mCherry-Lifeact were captured in every 10 seconds. Numbers indicate minutes:seconds. (AVI 6245 kb)

Inhibition of microtubule function in the course of mitosis.

HeLa cells co-expressing mCherry-H2B and GFP-tubulin with CIB1-MP (the left video) or CRY2-VHH(GFP) (the center video) or both CRY2-VHH(GFP) and CIB1-MP (the right video) were exposed to blue light (488 nm) at 5-minute intervals for 24 hours. Fluorescent images of mCherry-H2B and GFP-tubulin were simultaneously captured in every 5 minutes. Numbers indicate hours:minutes. (AVI 23919 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S., Park, H., Kyung, T. et al. Reversible protein inactivation by optogenetic trapping in cells. Nat Methods 11, 633–636 (2014). https://doi.org/10.1038/nmeth.2940

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth.2940

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing